- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05760352
Comparison of Multiple Exercise Trainings in Chronic Respiratory Disease
Comparison of Multiple Methods of Exercise Training for Accessing Maximal Oxygen Consumption, Skeletal Muscle Oxygen Saturation, and Cardiopulmonary Outcomes in Patients With Chronic Respiratory Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Chronic respiratory and chronic obstructive pulmonary disease is the one of the major causes of global morbidity and mortality. Patients with chronic respiratory disease often experience exercise limitation and physical inactivity due to muscular weakness and severe dyspnea. Symptoms of COPD may contribute to activity restriction, deconditioning, and exercise intolerance. Pulmonary rehabilitation has been demonstrated to improve clinical outcomes and exercise capacity in patients with chronic respiratory disease. However, the optimal exercise training modality is remaining unclear.
Study Design: This is a one-year, single-centre, prospective randomized controlled trial
Methods: The investigators expected a total of 60 participants were be enrolled, then randomly assigned into three groups (control group, experimental-1, and experimental-2). All participants will receive a graded exercise test, then followed a 9-weeks of exercise training. After 9-weeks of exercise training, the maximal oxygen consumption will be analyzed as a primary outcome of this study. Physiological parameters, hemodynamic outcome, respiratory function, and strength of lower limb muscle will be recorded.
Effect: After 9 weeks' exercise training, VO2 will significantly improve in eccentric cycling exercise groups, furthermore, heart rate and perceived exertion will be lower in the eccentric cycling exercise combined with helmet ventilation.
Key words: Pulmonary rehabilitation; eccentric cycling exercise; helmet ventilation; chronic respiratory disease
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
New Taipei City, Taiwan, 24352
- Fu Jen Catholic University Hospital, Fu Jen Catholic University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 20 and 80 years
- Diagnosed with chronic respiratory diseases
- Having undergone pulmonary rehabilitation for more than 3 months
Exclusion Criteria:
- Existing of tracheostomy
- Those who use oxygen therapy or ventilator at home
- Severe left heart failure (NYHA III-IV)
- Neuromuscular disease
- Acute exacerbation within the past three months
- Those who are unable to cooperate with the cardiopulmonary exercise test
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Self-paced exercise
|
|
|
Experimental: Intervention Group: eccentric cycling exercise
Received eccentric cycling exercise
|
Received eccentric cycling exercise
|
|
Experimental: Intervention Group: eccentric cycling exercise with helmet ventilation
Eccentric cycling exercise combined with helmet ventilation
|
Received eccentric cycling exercise
Using helmet ventilation during eccentric cycling exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak % of oxygen consumption
Time Frame: 9 weeks
|
To observe the maximum exercise performance
|
9 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate, b/m
Time Frame: 9 weeks
|
Cardiac hemodynamic parameter
|
9 weeks
|
|
Respiratory rate, b/m
Time Frame: 9 weeks
|
Pulmonary parameter
|
9 weeks
|
|
Mean arterial blood pressure, mmHg
Time Frame: 9 weeks
|
Cardiac hemodynamic parameter
|
9 weeks
|
|
FEV1/FVC, %
Time Frame: 9 weeks
|
Pulmonary function
|
9 weeks
|
|
Saturation of Peripheral Oxygen(SpO2), %
Time Frame: 9 weeks
|
Blood oxygenation
|
9 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ke-Yun Chao, PhD, Fu Jen Catholic University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FJUH111193
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pulmonary Disease
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
Astellas Pharma Global Development, Inc.CytokineticsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruitingChronic Obstructive Pulmonary Disease (COPD)France
-
Ankara UniversityRecruitingChronic Obstructive Pulmonary Disease (COPD)Turkey
-
Nanfang Hospital, Southern Medical UniversityEnrolling by invitationChronic Obstructive Pulmonary Disease (COPD)China
Clinical Trials on Eccentric bike
-
Fu Jen Catholic UniversityWithdrawnCOPD (Chronic Obstructive Pulmonary Disease)Taiwan
-
Fu Jen Catholic UniversityRecruiting
-
Cara J. HamannEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAdolescent | Attitudes | Education | Self Efficacy | Behavior | Safety | Knowledge | Practice | BicyclingUnited States
-
Mersin UniversityCompleted
-
Indiana UniversityNot yet recruitingDelirium | Fall | Deep Venous Thrombosis | Mobility Limitation | Hospital Acquired Condition | Immobility Syndrome
-
University Hospital, BonnRecruiting
-
IRCCS Eugenio MedeaPolitecnico di Milano; Villa Beretta Rehabilitation Center; National Research...Completed
-
Taipei Veterans General Hospital, TaiwanCompletedIntensive Care Unit PatientsTaiwan
-
Peking University First HospitalCompleted
-
University of YalovaCompletedAthletic Performance | Muscle Strength | Balance | Physical PerformanceTurkey (Türkiye)